2012 annual financial data
Neuphoria Therapeutics 2012 Operating cash flow margin
Neuphoria Therapeutics 2012 operating cash flow margin with verified reported v…
Direct answer
Operating cash flow margin was -55.1%.
Operating income was -12,213,387 USD and net income was -3,209,609 USD.
Operating cash flow was -2,945,800 USD.
Get free Neuphoria Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 5,346,156 USD
- Operating income
- -12,213,387 USD
- Net income
- -3,209,609 USD
- Operating cash flow
- -2,945,800 USD